Brightgene Bio-medical Technology Co., Ltd.

This early-stage study tested a new injection called BGM0504 in 30 overweight or obese adults who do not have diabetes. The main goal was to check safety and side effects, and researchers also measured weight changes over 10 weeks. Participants received either the drug or a place…

This study looked at how an experimental injection called BGM0504 affects stomach emptying and the way the body processes two common drugs—metformin and warfarin—in overweight or obese adults. 28 participants completed the trial, which measured drug levels in the blood. The goal …

This study looked at how the body absorbs and removes the drug BGM0504 in people with reduced kidney function compared to healthy volunteers. A total of 34 adults with type 2 diabetes or overweight/obesity took part. The goal was to understand if kidney problems change how the dr…